Titan Medical engages in the design and development of SPORT single-port robotic surgical system for minimally invasive surgery (MIS).
Titan Medical Inc., a development stage company, engages in the design and development of SPORT single-port robotic surgical system for application in minimally invasive surgery (MIS).
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 26, 2022 | Post-IPO Debt | $10.60M | 1 | Medtronic | — | Detail |
Feb 24, 2021 | Post-IPO Equity | $34.50M | — | — | — | Detail |
Jun 8, 2020 | Post-IPO Equity | $18M | — | — | — | Detail |
May 4, 2020 | Post-IPO Equity | $2M | — | — | — | Detail |
Apr 29, 2020 | Debt Financing | $1.50M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Medtronic | Yes | Post-IPO Debt |
Aspire Capital Partners LLC | Yes | Post-IPO Equity |
Shanghai Jugu Equity Investment Fund | — | Post-IPO Equity |